Latest filing published 12 Aug 2026 for TAKEDA PHARMACEUTICAL CO LTD, €207k.
No signal scores available.
All filings by Awny Samaan Botros Farajallah on record concern Takeda Pharmaceutical Co Ltd. The record holds 2 filings, for trades running from 1 July 2026 to 10 August 2026.
Every open-market trade on record is a sale: 1 sale worth €207k. Besides market trades, the filings include 1 share grant.
On 12 August 2026 came the latest disclosure, an open-market sale for €207k in Takeda Pharmaceutical Co Ltd. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations